Corcept Therapeutics (CORT) Holding Has Upped by Timpani Capital Management Llc; Gilead Sciences (GILD) Shareholder Nikko Asset Management Americas Decreased Its Holding as Market Valuation Declined

February 16, 2018 - By Peter Erickson

Nikko Asset Management Americas Inc decreased its stake in Gilead Sciences Inc (GILD) by 82.91% based on its latest 2017Q3 regulatory filing with the SEC. Nikko Asset Management Americas Inc sold 29,100 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 6,000 shares of the health care company at the end of 2017Q3, valued at $486,000, down from 35,100 at the end of the previous reported quarter. Nikko Asset Management Americas Inc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $107.36B market cap company. The stock increased 0.78% or $0.63 during the last trading session, reaching $82.18. About 2.42M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 16, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Timpani Capital Management Llc increased its stake in Corcept Therapeutics Inc (CORT) by 38.1% based on its latest 2017Q3 regulatory filing with the SEC. Timpani Capital Management Llc bought 47,923 shares as the company’s stock rose 42.01% with the market. The institutional investor held 173,711 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $3.35 million, up from 125,788 at the end of the previous reported quarter. Timpani Capital Management Llc who had been investing in Corcept Therapeutics Inc for a number of months, seems to be bullish on the $1.84 billion market cap company. The stock increased 3.86% or $0.6 during the last trading session, reaching $16.16. About 547,380 shares traded. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 124.81% since February 16, 2017 and is uptrending. It has outperformed by 108.11% the S&P500.

Among 4 analysts covering Corcept Therapeutics (NASDAQ:CORT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Corcept Therapeutics had 7 analyst reports since February 2, 2017 according to SRatingsIntel. Ladenburg Thalmann initiated the shares of CORT in report on Thursday, February 2 with “Buy” rating. Piper Jaffray maintained it with “Buy” rating and $24.0 target in Wednesday, October 11 report. The stock of Corcept Therapeutics Incorporated (NASDAQ:CORT) has “Buy” rating given on Friday, November 3 by Stifel Nicolaus. The rating was maintained by Piper Jaffray with “Buy” on Friday, September 8. The company was maintained on Thursday, August 24 by Piper Jaffray.

Timpani Capital Management Llc, which manages about $202.98 million and $274.08 million US Long portfolio, decreased its stake in Lendingtree Inc (NASDAQ:TREE) by 5,933 shares to 24,456 shares, valued at $5.98M in 2017Q3, according to the filing. It also reduced its holding in Advanced Energy Industries In (NASDAQ:AEIS) by 7,873 shares in the quarter, leaving it with 34,483 shares, and cut its stake in Addus Homecare Corp (NASDAQ:ADUS).

Since December 8, 2017, it had 0 insider buys, and 3 selling transactions for $415,899 activity.

Investors sentiment decreased to 1.96 in 2017 Q3. Its down 0.47, from 2.43 in 2017Q2. It fall, as 13 investors sold CORT shares while 39 reduced holdings. 47 funds opened positions while 55 raised stakes. 71.96 million shares or 6.38% more from 67.64 million shares in 2017Q2 were reported. Victory Capital Inc stated it has 5,584 shares or 0% of all its holdings. National Asset Mngmt reported 12,376 shares. Cubist Systematic Strategies Limited owns 25,080 shares. Natixis invested in 11,354 shares. State Board Of Administration Of Florida Retirement System stated it has 44,813 shares or 0% of all its holdings. 15,112 were reported by Creative Planning. Great West Life Assurance Can accumulated 7,612 shares. Castleark Mngmt Ltd Llc owns 0.11% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 182,252 shares. Investor Ab holds 0.93% or 750,423 shares in its portfolio. Consonance Capital Limited Partnership owns 3.88 million shares for 8.29% of their portfolio. Numeric holds 0.05% or 361,413 shares. Eam Ltd stated it has 72,542 shares or 0.19% of all its holdings. Smith Asset LP stated it has 266,085 shares or 0.17% of all its holdings. Sit Inv Assoc has invested 0.03% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). Fuller Thaler Asset Management Inc has 145,100 shares for 0.03% of their portfolio.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Los Angeles Capital & Equity has invested 0.15% in Gilead Sciences, Inc. (NASDAQ:GILD). Korea Invest accumulated 0.43% or 1.16 million shares. Blue Finance Capital has 0.3% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 5,988 shares. Moreover, Fifth Third State Bank has 0.67% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 1.15 million shares. Fort Washington Oh invested in 0.22% or 175,139 shares. Quantres Asset Mgmt Ltd reported 13,500 shares or 0.7% of all its holdings. World Invsts holds 5.03 million shares or 0.09% of its portfolio. Keybank National Association Oh reported 0.26% in Gilead Sciences, Inc. (NASDAQ:GILD). Moreover, Bogle Invest Management Ltd Partnership De has 0.72% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 131,376 shares. Weiss Multi invested in 0.15% or 50,000 shares. Cornerstone Capital holds 0.73% in Gilead Sciences, Inc. (NASDAQ:GILD) or 51,236 shares. Moreover, Capital Guardian Tru has 0.11% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 74,502 shares. Ims Mgmt stated it has 0.93% in Gilead Sciences, Inc. (NASDAQ:GILD). First Mercantile invested 0.49% in Gilead Sciences, Inc. (NASDAQ:GILD). Mutual Of Omaha Bancorporation Wealth reported 10,153 shares or 0.3% of all its holdings.

Since August 30, 2017, it had 0 buys, and 13 insider sales for $51.09 million activity. The insider MARTIN JOHN C sold $6.05 million. Meyers James R sold $8.02M worth of stock or 100,000 shares. 51,820 shares were sold by Washington Robin L, worth $4.40 million.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>